XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.24.3

STOCKHOLDERS' EQUITY (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Equity [Abstract] |
Schedule of Stockholders Equity | The following tables present the changes in stockholders’ equity (in millions):
| Three Months Ended September 30, 2024
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 355.3 |  |  | $ | 0.4 |  |  | $ | 9,149.7 |  |  | $ | 5,581.7 |  |  | $ | (23.5) |  |  | $ | 14,708.3 |  |  | $ | 88.2 |  |  | $ | 14,796.5 |
Issuance of common stock through employee stock plans | 1.0 |  |  | — |  |  | 115.6 |  |  | — |  |  | — |  |  | 115.6 |  |  | — |  |  | 115.6 |
Shares withheld related to net share settlement of equity awards | (0.1) |  |  | — |  |  | (0.4) |  |  | (17.0) |  |  | — |  |  | (17.4) |  |  | — |  |  | (17.4) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 175.3 |  |  | — |  |  | — |  |  | 175.3 |  |  | — |  |  | 175.3 |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 565.1 |  |  | — |  |  | 565.1 |  |  | — |  |  | 565.1 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 36.4 |  |  | 36.4 |  |  | 0.5 |  |  | 36.9 |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 5.5 |  |  | 5.5 |
Ending balance | 356.2 |  |  | $ | 0.4 |  |  | $ | 9,440.2 |  |  | $ | 6,129.8 |  |  | $ | 12.9 |  |  | $ | 15,583.3 |  |  | $ | 94.2 |  |  | $ | 15,677.5 |
| Three Months Ended September 30, 2023
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 351.3 |  |  | $ | 0.4 |  |  | $ | 8,150.8 |  |  | $ | 3,807.7 |  |  | $ | (79.8) |  |  | $ | 11,879.1 |  |  | $ | 80.6 |  |  | $ | 11,959.7 |
Issuance of common stock through employee stock plans | 0.7 |  |  | — |  |  | 77.4 |  |  | — |  |  | — |  |  | 77.4 |  |  | — |  |  | 77.4 |
Shares withheld related to net share settlement of equity awards | — |  |  | — |  |  | (0.6) |  |  | (14.2) |  |  | — |  |  | (14.8) |  |  | — |  |  | (14.8) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 158.3 |  |  | — |  |  | — |  |  | 158.3 |  |  | — |  |  | 158.3 |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 415.7 |  |  | — |  |  | 415.7 |  |  | — |  |  | 415.7 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | 23.3 |  |  | 23.3 |  |  | (0.2) |  |  | 23.1 |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4.1 |  |  | 4.1 |
Ending balance | 352.0 |  |  | $ | 0.4 |  |  | $ | 8,385.9 |  |  | $ | 4,209.2 |  |  | $ | (56.5) |  |  | $ | 12,539.0 |  |  | $ | 84.5 |  |  | $ | 12,623.5 |
| Nine Months Ended September 30, 2024
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 352.3 |  |  | $ | 0.4 |  |  | $ | 8,576.4 |  |  | $ | 4,743.0 |  |  | $ | (12.2) |  |  | $ | 13,307.6 |  |  | $ | 89.7 |  |  | $ | 13,397.3 |
Issuance of common stock through employee stock plans | 4.6 |  |  | — |  |  | 367.5 |  |  | — |  |  | — |  |  | 367.5 |  |  | — |  |  | 367.5 |
Shares withheld related to net share settlement of equity awards | (0.7) |  |  | — |  |  | (7.4) |  |  | (250.1) |  |  | — |  |  | (257.5) |  |  | — |  |  | (257.5) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 503.7 |  |  | — |  |  | — |  |  | 503.7 |  |  | — |  |  | 503.7 |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 1,636.9 |  |  | — |  |  | 1,636.9 |  |  | — |  |  | 1,636.9 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | 25.1 |  |  | 25.1 |  |  | (0.1) |  |  | 25.0 |
Cash dividends declared and paid by joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (8.0) |  |  | (8.0) |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 12.6 |  |  | 12.6 |
Ending balance | 356.2 |  |  | $ | 0.4 |  |  | $ | 9,440.2 |  |  | $ | 6,129.8 |  |  | $ | 12.9 |  |  | $ | 15,583.3 |  |  | $ | 94.2 |  |  | $ | 15,677.5 |
| Nine Months Ended September 30, 2023
| Common Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Intuitive Surgical, Inc. Stockholders’ Equity |  | Noncontrolling Interest in Joint Venture |  | Total Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |
Beginning balance | 350.0 |  |  | $ | 0.4 |  |  | $ | 7,703.9 |  |  | $ | 3,500.1 |  |  | $ | (162.5) |  |  | $ | 11,041.9 |  |  | $ | 70.7 |  |  | $ | 11,112.6 |
Issuance of common stock through employee stock plans | 4.1 |  |  | — |  |  | 252.2 |  |  | — |  |  | — |  |  | 252.2 |  |  | — |  |  | 252.2 |
Shares withheld related to net share settlement of equity awards | (0.6) |  |  | — |  |  | (6.9) |  |  | (148.5) |  |  | — |  |  | (155.4) |  |  | — |  |  | (155.4) |
Share-based compensation expense related to employee stock plans | — |  |  | — |  |  | 452.5 |  |  | — |  |  | — |  |  | 452.5 |  |  | — |  |  | 452.5 |
Repurchase and retirement of common stock | (1.5) |  |  | — |  |  | (15.8) |  |  | (334.2) |  |  | — |  |  | (350.0) |  |  | — |  |  | (350.0) |
Net income attributable to Intuitive Surgical, Inc. | — |  |  | — |  |  | — |  |  | 1,191.8 |  |  | — |  |  | 1,191.8 |  |  | — |  |  | 1,191.8 |
Other comprehensive income (loss) | — |  |  | — |  |  | — |  |  | — |  |  | 106.0 |  |  | 106.0 |  |  | (1.0) |  |  | 105.0 |
Net income attributable to noncontrolling interest in joint venture | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 14.8 |  |  | 14.8 |
Ending balance | 352.0 |  |  | $ | 0.4 |  |  | $ | 8,385.9 |  |  | $ | 4,209.2 |  |  | $ | (56.5) |  |  | $ | 12,539.0 |  |  | $ | 84.5 |  |  | $ | 12,623.5 |
Schedule of Share Repurchase Activities | The following table summarizes stock repurchase activities (in millions, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Shares repurchased | — |  |  | — |  |  | — |  |  | 1.5 |
Average price per share | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 238.1 |
Value of shares repurchased | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 350.0 |
Components of Accumulated Other Comprehensive Income, Net of Tax | The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive Surgical, Inc. are as follows (in millions):
| Three Months Ended September 30, 2024
| Gains (Losses) on Hedge Instruments |  | Unrealized Gains (Losses) on Available-for-Sale Securities |  | Foreign Currency Translation Losses |  | Employee Benefit Plans |  | Total
Beginning balance | $ | 7.9 |  |  | $ | (28.4) |  |  | $ | (3.5) |  |  | $ | 0.5 |  |  | $ | (23.5) |
Other comprehensive income (loss) before reclassifications | (15.7) |  |  | 59.5 |  |  | (7.4) |  |  | — |  |  | 36.4 |
Amounts reclassified from accumulated other comprehensive income (loss) | 0.2 |  |  | — |  |  | — |  |  | (0.2) |  |  | — |
Net current-period other comprehensive income (loss) | (15.5) |  |  | 59.5 |  |  | (7.4) |  |  | (0.2) |  |  | 36.4 |
Ending balance | $ | (7.6) |  |  | $ | 31.1 |  |  | $ | (10.9) |  |  | $ | 0.3 |  |  | $ | 12.9 |
| Three Months Ended September 30, 2023
| Gains on Hedge Instruments |  | Unrealized Losses on Available-for-Sale Securities |  | Foreign Currency Translation Gains |  | Employee Benefit Plans |  | Total
Beginning balance | $ | 5.6 |  |  | $ | (103.5) |  |  | $ | 16.9 |  |  | $ | 1.2 |  |  | $ | (79.8) |
Other comprehensive income (loss) before reclassifications | 2.0 |  |  | 25.6 |  |  | (6.6) |  |  | — |  |  | 21.0 |
Amounts reclassified from accumulated other comprehensive income | 2.3 |  |  | — |  |  | — |  |  | — |  |  | 2.3 |
Net current-period other comprehensive income (loss) | 4.3 |  |  | 25.6 |  |  | (6.6) |  |  | — |  |  | 23.3 |
Ending balance | $ | 9.9 |  |  | $ | (77.9) |  |  | $ | 10.3 |  |  | $ | 1.2 |  |  | $ | (56.5) |
| Nine Months Ended September 30, 2024
| Losses on Hedge Instruments |  | Unrealized Gains (Losses) on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | (2.5) |  |  | $ | (29.7) |  |  | $ | 19.4 |  |  | $ | 0.6 |  |  | $ | (12.2) |
Other comprehensive income (loss) before reclassifications | (10.5) |  |  | 60.6 |  |  | (30.3) |  |  | — |  |  | 19.8 |
Amounts reclassified from accumulated other comprehensive income (loss) | 5.4 |  |  | 0.2 |  |  | — |  |  | (0.3) |  |  | 5.3 |
Net current-period other comprehensive income (loss) | (5.1) |  |  | 60.8 |  |  | (30.3) |  |  | (0.3) |  |  | 25.1 |
Ending balance | $ | (7.6) |  |  | $ | 31.1 |  |  | $ | (10.9) |  |  | $ | 0.3 |  |  | $ | 12.9 |
| Nine Months Ended September 30, 2023
| Gains (Losses) on Hedge Instruments |  | Unrealized Losses on Available-for-Sale Securities |  | Foreign Currency Translation Gains (Losses) |  | Employee Benefit Plans |  | Total
Beginning balance | $ | (2.9) |  |  | $ | (154.2) |  |  | $ | (6.6) |  |  | $ | 1.2 |  |  | $ | (162.5) |
Other comprehensive income before reclassifications | 12.6 |  |  | 76.5 |  |  | 16.9 |  |  | — |  |  | 106.0 |
Amounts reclassified from accumulated other comprehensive income (loss) | 0.2 |  |  | (0.2) |  |  | — |  |  | — |  |  | — |
Net current-period other comprehensive income | 12.8 |  |  | 76.3 |  |  | 16.9 |  |  | — |  |  | 106.0 |
Ending balance | $ | 9.9 |  |  | $ | (77.9) |  |  | $ | 10.3 |  |  | $ | 1.2 |  |  | $ | (56.5) |
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) | The tax impacts for amounts recognized in other comprehensive income before reclassifications were as follows (in millions):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Available-for-sale securities | 2024 |  | 2023 |  | 2024 |  | 2023
Income tax benefit (expense) for net gains (losses) recorded in other comprehensive income | $ | (17.5) |  |  | $ | (7.4) |  |  | $ | (17.8) |  |  | $ | (22.0) |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 + Details
Name: | us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1 + Details
Name: | us-gaap_ScheduleOfTreasuryStockByClassTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration